Sign in

CIK 0001595097 · Non-accelerated filer<br>Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464348039
Phone
617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,758,438
in 2 filings, $16K under 10b5-1 plans

Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-12-11 Cormorant Asset Management, LP 10% owner Sale −30,029 $11.46 $344K 2,344,971
2025-10-27 Cohen Yuval Chief Executive Officer Option exercise 10b5-1 +8,973 $4.26 $38K 147,160
2025-10-27 Cohen Yuval Chief Executive Officer Sale 10b5-1 −8,973 $17.14 $154K 138,187
2025-10-27 Cohen Yuval Chief Executive Officer Option exercise · Stock options (right to buy) 10b5-1 −8,973 22,106
2025-10-24 Cohen Yuval Chief Executive Officer Option exercise 10b5-1 +18,660 $4.26 $79K 156,847
2025-10-24 Cohen Yuval Chief Executive Officer Sale 10b5-1 −18,660 $17.01 $317K 138,187
2025-10-24 Cohen Yuval Chief Executive Officer Option exercise · Stock options (right to buy) 10b5-1 −18,660 31,079
2025-10-24 Moran Sean F. Chief Financial Officer Option exercise 10b5-1 +12,981 $4.26 $55K 86,294
2025-10-24 Moran Sean F. Chief Financial Officer Sale 10b5-1 −12,981 $17.02 $221K 73,313
2025-10-24 Moran Sean F. Chief Financial Officer Option exercise · Stock options (right to buy) 10b5-1 −12,981 10,386
2025-10-20 Altmeyer Anne Director Option exercise 10b5-1 +1,060 $4.80 $5K 7,251
2025-10-20 Altmeyer Anne Director Sale 10b5-1 −1,060 $20.50 $22K 6,191
2025-10-20 Altmeyer Anne Director Option exercise · Stock options (right to buy) 10b5-1 −1,060 4,247
2025-05-30 Kung Winston Director Grant or award +4,800 10,366
2025-05-30 Kung Winston Director Grant or award · Stock options (right to buy) +16,000 16,000
2025-05-30 Ben Yong Director Grant or award +4,800 7,583
2025-05-30 Ben Yong Director Grant or award · Stock options (right to buy) +16,000 16,000
2025-05-30 Jenkins John Kenneth Director Sale 10b5-1 −2,783 $7.35 $20K 33
2025-05-30 Jenkins John Kenneth Director Grant or award 10b5-1 +4,800 4,833
2025-05-30 Jenkins John Kenneth Director Grant or award · Stock options (right to buy) 10b5-1 +16,000 16,000

Page 3 of 10 · 200 trades